Tadashi Fujino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tadashi Fujino has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Masaya Shinohara
Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, NY
8 shared publications Shintaro Yao
Department of Cardiovascular Medicine, Toho University Faculty of Medicine , 6-11-1 Omorinishi, Ota-ku, Tokyo 143-8541
8 shared publicationsTakanori Ikeda
Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo, Japan
8 shared publicationsAtsushi Takahashi
Cardiovascular Center, Yokosuka Kyosai Hospital, Yokosuka, Japan
7 shared publications- Takanori Ikeda
Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo 143-8541, Japan
7 shared publications Hitomi Yuzawa
6 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (11) , ytag810
Hybrid surgical-electrophysiological epicardial cryoablation for ventricular tachycardia storm from a deep intramural substrate in hypertrophic cardiomyopathy: a case report
Background: Ventricular tachycardia (VT) associated with hypertrophic cardiomyopathy (HCM) may arise from deep intramural substrates and remains challenging to treat when conventional endocardial or percutaneous epicardial approaches are ineffective or infeasible. Case summary: A 63-year-old man with HCM presented with drug-resistant VT storm. Endocardial mapping showed marked narrowing of the left ventricular (LV) cavity at the midventricular level, without abnormal potentials. Pace mapping demonstrated the closest match at the distal anterolateral coronary venous branch, suggesting a deep intramural origin. A subxiphoid epicardial approach was precluded by prior oesophageal reconstruction; therefore, minimally invasive cardiac surgery via left thoracotomy enabled epicardial cryoablation using the cryoICE system. Epicardial mapping during VT revealed a low-voltage area with fractionated electrograms at the apicolateral LV. Activation time did not span the full VT cycle length, suggesting an epicardial exit with a deep intramural isthmus. VT terminated during the first cryoapplication, followed by two additional applications (total 15 min). No VT recurrence was observed during 1 year of follow-up after discontinuation of amiodarone. Postprocedural cardiac magnetic resonance demonstrated transmural enhancement at the cryoablation target site despite a myocardial thickness of approximately 15 mm, suggesting successful deep lesion formation. Discussion: This case demonstrated that hybrid surgical-electrophysiological cryoablation can provide effective treatment for VT arising from deep intramural substrates when conventional endocardial and percutaneous epicardial approaches are ineffective or infeasible. Surgical cryoablation was associated with transmural enhancement despite marked myocardial hypertrophy and resulted in durable arrhythmia suppression.
- 27 October 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (11) , ytag810
Open AccessHybrid surgical-electrophysiological epicardial cryoablation for ventricular tachycardia storm from a deep intramural substrate in hypertrophic cardiomyopathy: a case report
Background: Ventricular tachycardia (VT) associated with hypertrophic cardiomyopathy (HCM) may arise from deep intramural substrates and remains challenging to treat when conventional endocardial or percutaneous epicardial approaches are ineffective or infeasible. Case summary: A 63-year-old man with HCM presented with drug-resistant VT storm. Endocardial mapping showed marked narrowing of the left ventricular (LV) cavity at the midventricular level, without abnormal potentials. Pace mapping demonstrated the closest match at the distal anterolateral coronary venous branch, suggesting a deep intramural origin. A subxiphoid epicardial approach was precluded by prior oesophageal reconstruction; therefore, minimally invasive cardiac surgery via left thoracotomy enabled epicardial cryoablation using the cryoICE system. Epicardial mapping during VT revealed a low-voltage area with fractionated electrograms at the apicolateral LV. Activation time did not span the full VT cycle length, suggesting an epicardial exit with a deep intramural isthmus. VT terminated during the first cryoapplication, followed by two additional applications (total 15 min). No VT recurrence was observed during 1 year of follow-up after discontinuation of amiodarone. Postprocedural cardiac magnetic resonance demonstrated transmural enhancement at the cryoablation target site despite a myocardial thickness of approximately 15 mm, suggesting successful deep lesion formation. Discussion: This case demonstrated that hybrid surgical-electrophysiological cryoablation can provide effective treatment for VT arising from deep intramural substrates when conventional endocardial and percutaneous epicardial approaches are ineffective or infeasible. Surgical cryoablation was associated with transmural enhancement despite marked myocardial hypertrophy and resulted in durable arrhythmia suppression.
- 11 September 2026
- Published by Elsevier in Journal of Electrocardiology
- Vol. 99, 154427
One-week patch ECG reveals residual atrial fibrillation missed by repeated Holter monitoring after apparently successful catheter ablation
- 11 September 2026
- Published by Elsevier in Journal of Electrocardiology
- Vol. 99, 154427
One-week patch ECG reveals residual atrial fibrillation missed by repeated Holter monitoring after apparently successful catheter ablation
- 7 January 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (3) , 700-704
Retrieval of an Aveir Leadless Pacemaker With a Standard Retrieval Catheter by Releasing the Wedged Docking Button Using a Loop Wire Technique
Introduction: The docking button of the Aveir leadless pacemaker (LP) is occasionally difficult to access due to its inappropriate position in the right ventricle (RV).Methods and Results: We report a case where the Aveir LP was successfully retrieved by releasing the wedged docking button in the inferior wall of the RV using a loop wire technique.Conclusion: The loop wire technique may be useful to change the position of the Aveir LP. This may be helpful to retrieve the Aveir LP even in a case where the docking button is wedged in the inferior wall of the RV.
- 7 January 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (3) , 700-704
Retrieval of an Aveir Leadless Pacemaker With a Standard Retrieval Catheter by Releasing the Wedged Docking Button Using a Loop Wire Technique
Introduction: The docking button of the Aveir leadless pacemaker (LP) is occasionally difficult to access due to its inappropriate position in the right ventricle (RV).Methods and Results: We report a case where the Aveir LP was successfully retrieved by releasing the wedged docking button in the inferior wall of the RV using a loop wire technique.Conclusion: The loop wire technique may be useful to change the position of the Aveir LP. This may be helpful to retrieve the Aveir LP even in a case where the docking button is wedged in the inferior wall of the RV.
- Open Access
- 18 May 2023
- Published by Elsevier in Heart Rhythm
- Vol. 20 (5) , S229
PO-01-066 IMPACT OF THE MORPHOLOGY-VOLTAGE-P-WAVE DURATION SCORE ON THE OUTCOME OF CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION
- 18 May 2023
- Published by Elsevier in Heart Rhythm
- Vol. 20 (5) , S229
Open AccessPO-01-066 IMPACT OF THE MORPHOLOGY-VOLTAGE-P-WAVE DURATION SCORE ON THE OUTCOME OF CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION
- Open Access
- 18 May 2023
- Published by Elsevier in Heart Rhythm
- Vol. 20 (5) , S329-S330
PO-02-032 IMPACT OF ATRIAL FIBRILLATION TRIGGERS ON LONG-TERM OUTCOMES OF A SECOND CATHETER ABLATION OF NON-PAROXYSMAL ATRIAL FIBRILLATION
- 18 May 2023
- Published by Elsevier in Heart Rhythm
- Vol. 20 (5) , S329-S330
Open AccessPO-02-032 IMPACT OF ATRIAL FIBRILLATION TRIGGERS ON LONG-TERM OUTCOMES OF A SECOND CATHETER ABLATION OF NON-PAROXYSMAL ATRIAL FIBRILLATION
- 3 October 2021
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 44 (11) , 1861-1873
Predictive value of the cardio‐ankle vascular index for recurrence of atrial fibrillation after catheter ablation
Background: The predictive value of the cardio‐ankle vascular index (CAVI) for estimating the efficacy outcome of catheter ablation (CA) in atrial fibrillation (AF) patients is unclear. We aimed to examine the predictive performance of the CAVI for recurrences of atrial arrhythmias after CA.Methods: We enrolled a total of 193 patients with AF (paroxysmal 126 and non‐paroxysmal 67) who underwent initial CA procedures at our institute, and CAVI measurements were conducted between January 2016 and March 2017. We evaluated recurrences of atrial arrhythmias after the first CA procedure as a clinical outcome. The CAVI value was assessed and the enrolled patients were divided according to the optimal CAVI value cut‐off point (9.5) in the atrial arrhythmia recurrence group.Results: During a mean follow‐up of 31.3 (17.5–43.0) months, 74 (32.5%; PaAF 41 and 49.3%; non‐PaAF 33) patients had recurrences of atrial arrhythmias. The recurrence ratio of atrial arrhythmias was significantly higher in patients with a high CAVI (≥9.5) than those with a low CAVI (p = 0.018). A univariate analysis showed the association between higher CAVI values and recurrences of atrial arrhythmias (p = 0.072). Multivariate analyses using a Cox proportional hazard model after adjusting for other clinical factors revealed that the CAVI value was determined to be a significant predictive factor of a recurrence of atrial arrhythmias after CA (Hazard ratio: 1.44, 95% confidence interval: 1.17–1.78, p < 0.01).Conclusions: The CAVI was significantly associated with a recurrence of atrial arrhythmias after CA in AF patients.
- 3 October 2021
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 44 (11) , 1861-1873
Predictive value of the cardio‐ankle vascular index for recurrence of atrial fibrillation after catheter ablation
Background: The predictive value of the cardio‐ankle vascular index (CAVI) for estimating the efficacy outcome of catheter ablation (CA) in atrial fibrillation (AF) patients is unclear. We aimed to examine the predictive performance of the CAVI for recurrences of atrial arrhythmias after CA.Methods: We enrolled a total of 193 patients with AF (paroxysmal 126 and non‐paroxysmal 67) who underwent initial CA procedures at our institute, and CAVI measurements were conducted between January 2016 and March 2017. We evaluated recurrences of atrial arrhythmias after the first CA procedure as a clinical outcome. The CAVI value was assessed and the enrolled patients were divided according to the optimal CAVI value cut‐off point (9.5) in the atrial arrhythmia recurrence group.Results: During a mean follow‐up of 31.3 (17.5–43.0) months, 74 (32.5%; PaAF 41 and 49.3%; non‐PaAF 33) patients had recurrences of atrial arrhythmias. The recurrence ratio of atrial arrhythmias was significantly higher in patients with a high CAVI (≥9.5) than those with a low CAVI (p = 0.018). A univariate analysis showed the association between higher CAVI values and recurrences of atrial arrhythmias (p = 0.072). Multivariate analyses using a Cox proportional hazard model after adjusting for other clinical factors revealed that the CAVI value was determined to be a significant predictive factor of a recurrence of atrial arrhythmias after CA (Hazard ratio: 1.44, 95% confidence interval: 1.17–1.78, p < 0.01).Conclusions: The CAVI was significantly associated with a recurrence of atrial arrhythmias after CA in AF patients.
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Significance of mitral L wave to predict late recurrence of atrial fibrillation after radiofrequency catheter ablation
Background: Mitral L wave, prominent mid-diastolic filling wave in echocardiographic examinations, is associated with severe left ventricular diastolic dysfunction, and that has been reported to predict recurrent atrial fibrillation (AF) after cardioversion. However, association between mitral L wave and the outcome of AF after radiofrequency catheter ablation (RFCA) has not been established. Objective: The aim of this study is to evaluate the predictive value of mitral L wave on AF recurrence after RFCA. Methods: 250 patients including 164 paroxysmal AF (65.6%) and 86 non-paroxysmal AF (34.4%) who received RFCA in single center from January 2015 to December 2016 were enrolled consecutively. Echocardiographic examinations before RFCA were recorded, and the mitral L wave was defined as a distinct mid-diastolic flow velocity with a peak velocity ≥20 cm/s following the E wave. Systematic follow-up was conducted after RFCA. Univariate and multivariate analyses were carried out to determine the factors predicting late recurrence of AF (LRAF) which means AF recurrence after 3 months. Enrolled patients were divided into groups with the L wave (L-group; n=57) or without the L wave (NL-group; n=193) based on the findings of echocardiographic examinations. Results: During a follow-up of 35.0±17.6 months, the ratio of LRAF in the L-group was significantly higher than that in the NL-group (32 (56.1%) vs. 41 (21.2%), Hazard ratio [HR]: 3.55, 95% confidence interval [CI]: 2.33 - 5.42, p<0.001). Among the clinical factors, presence of mitral L wave, BNP value, non-paroxysmal AF and moderate-severe mitral regurgitation were related to LRAF. A multivariate analysis using a Cox proportional hazard model found that presence of mitral L wave (HR: 2.67, 95% CI: 1.30 - 5.48, p=0.007) was significantly associated with LRAF. Conclusion: This study revealed that mitral L wave predicts late recurrence of AF after RFCA. Funding Acknowledgement: Type of funding sources: None.
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Significance of mitral L wave to predict late recurrence of atrial fibrillation after radiofrequency catheter ablation
Background: Mitral L wave, prominent mid-diastolic filling wave in echocardiographic examinations, is associated with severe left ventricular diastolic dysfunction, and that has been reported to predict recurrent atrial fibrillation (AF) after cardioversion. However, association between mitral L wave and the outcome of AF after radiofrequency catheter ablation (RFCA) has not been established. Objective: The aim of this study is to evaluate the predictive value of mitral L wave on AF recurrence after RFCA. Methods: 250 patients including 164 paroxysmal AF (65.6%) and 86 non-paroxysmal AF (34.4%) who received RFCA in single center from January 2015 to December 2016 were enrolled consecutively. Echocardiographic examinations before RFCA were recorded, and the mitral L wave was defined as a distinct mid-diastolic flow velocity with a peak velocity ≥20 cm/s following the E wave. Systematic follow-up was conducted after RFCA. Univariate and multivariate analyses were carried out to determine the factors predicting late recurrence of AF (LRAF) which means AF recurrence after 3 months. Enrolled patients were divided into groups with the L wave (L-group; n=57) or without the L wave (NL-group; n=193) based on the findings of echocardiographic examinations. Results: During a follow-up of 35.0±17.6 months, the ratio of LRAF in the L-group was significantly higher than that in the NL-group (32 (56.1%) vs. 41 (21.2%), Hazard ratio [HR]: 3.55, 95% confidence interval [CI]: 2.33 - 5.42, p<0.001). Among the clinical factors, presence of mitral L wave, BNP value, non-paroxysmal AF and moderate-severe mitral regurgitation were related to LRAF. A multivariate analysis using a Cox proportional hazard model found that presence of mitral L wave (HR: 2.67, 95% CI: 1.30 - 5.48, p=0.007) was significantly associated with LRAF. Conclusion: This study revealed that mitral L wave predicts late recurrence of AF after RFCA. Funding Acknowledgement: Type of funding sources: None.
- 1 April 2021
- Published by Elsevier in Journal of Cardiology
- Vol. 77 (4) , 388-394
Early electrocardiographic indices for predicting chronic doxorubicin-induced cardiotoxicity
- 1 April 2021
- Published by Elsevier in Journal of Cardiology
- Vol. 77 (4) , 388-394
Early electrocardiographic indices for predicting chronic doxorubicin-induced cardiotoxicity
- 1 October 2020
- Published by Elsevier in Journal of Cardiology
- Vol. 76 (4) , 420-426
Clinical characteristics of challenging catheter ablation procedures in patients with WPW syndrome: A 10 year single-center experience
- 1 October 2020
- Published by Elsevier in Journal of Cardiology
- Vol. 76 (4) , 420-426
Clinical characteristics of challenging catheter ablation procedures in patients with WPW syndrome: A 10 year single-center experience